BOSTON & GENEVA--(BUSINESS WIRE)-- Mass High Tech (MHT) and its sister publication The Boston Business Journal (BBJ) have named Philip Lee, PHT Corporation President and CEO, a “Tech Luminary” in their 2012 Innovation All Stars award program. PHT is the leading provider of systems used to collect Patient-Driven eData for clinical research.
Philip Lee, President & CEO of PHT Corporation (Photo: Business Wire)
MHT and the BBJ cover business, technology and the people and companies behind the innovation economy.
Christopher McIntosh, Publisher of the BBJ and MHT, said, “MHT's 15 ‘Tech Luminaries’ choices reflect deep accomplishment in various technology related industries. Together with the 15 ‘Rising Stars’ chosen by the BBJ, it's a potent combination of 30 notable and potent players in the local economy, and we hope their success will inspire others to innovate, which is the main driving force of the Boston economy.”
BBJ and MHT will host an Innovation All Stars celebration on November 14 at the House of Blues.
Under Philip Lee’s leadership PHT has commercialized technologies that automate the collection of outcomes from participants in clinical research. Recent innovations include the first smartphone app and Web browser based systems for collecting data from clinical trial participants.
Mr. Lee’s recent honors include being a finalist for the highly competitive Ernst & Young Entrepreneur of the Year Award; being named to the PharmaVOICE 100 list of the most influential people in the life sciences industries; being a finalist for the MassTLC CEO of the Year; and, being a finalist for CEO of the Year in SCRIP Clinical Research’s international award program. PHT’s business and industry recognition this year includes placement on BBJ’s Pacesetters list of the fastest growing companies in New England, as well as the Inc. 500/5000 list of the fastest growing private companies in the U.S.
Philip Lee said, “I am honored by this recognition from BBJ and MHT, two publications that are tuned into the latest innovations and trends in the local and national business and technology communities. Every day I look forward to working with PHT’s world-class team and to helping our customers and partners leverage innovative technologies that improve patient safety and bring important new therapies to market faster.”
About PHT Corporation
PHT Corporation helps biopharmaceutical companies and CROs conduct clinical studies with greater confidence, ease and accuracy. We enable our clients to gain insights, through measuring how patients feel and function, that help speed therapies to market and improve lives. From our 500+ global trial experiences including 16+ regulatory approvals, we offer the breadth, history and scientific expertise today’s market demands. PHT's proven Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via PHT’s StudyWorks® online portal, provides sponsors and clinicians with a real-time window to patients between visits for improved protocol compliance and safety monitoring. For more information on Patient-Driven eData, review the interactive content and demonstrations at phtcorp.com. Follow PHT on Twitter.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50423579&lang=en
For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com
Source: PHT Corporation